Journal List > Dement Neurocogn Disord > v.15(4) > 1120238

Dement Neurocogn Disord. 2016 Dec;15(4):159-164. English.
Published online Dec 31, 2016.  https://doi.org/10.12779/dnd.2016.15.4.159
© 2016 Korean Dementia Association
Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
Sangsoon Kim,1 Yeonwook Kang,2,3 Kyung-Ho Yu,3 and Byung-Chul Lee3
1Department of Psychiatry, Gachon University Gil Medical Center, Incheon, Korea.
2Department of Psychology, Hallym University, Chuncheon, Korea.
3Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.

Correspondence: Yeonwook Kang, PhD, Department of Psychology, Hallym University, 1 Hallimdaehak-gil, Chuncheon 24252, Korea. Tel: +82-33-248-1724, Fax: +82-33-256-3424, Email: ykang@hallym.ac.kr
Received Nov 21, 2016; Revised Dec 19, 2016; Accepted Dec 19, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Abstract

Background and Purpose

Many literatures indicate that executive dysfunction exists in mild cognitive impairment (MCI) as well as Alzheimer’s disease (AD). However, there are few studies that found how early the deficits of the executive function (EF) exist in MCI. The present study investigated the presence of executive dysfunctions in the earliest stage of MCI, and the sub-domains of EF which are disproportionately impaired earlier than others.

Methods

The participants were 41 normal elderly (NE), 86 with amnestic multi-domain MCI, and 41 with mild AD. The MCI group was further sub-divided into two groups: Early MCI (EMCI, n=45) and late MCI (n=41), based on the Clinical Dementia Rating-Sum of Boxes. All participants were given neuropsychological tests to assess the sub-domains of EF, such as verbal fluency, psychomotor speed, inhibitory control, and mental set-shifting.

Results

Impairment of semantic fluency was observed in EMCI, with gradual worsening as cases approached mild AD. Phonemic fluency and psychomotor speed were also impaired at the early stage of MCI relative to the NE, but maintained at the same level up to mild AD. EMCI exhibited the same degree of performance with NE for inhibitory control and mental set-shifting; however, they progressively worsened from EMCI to mild AD.

Conclusions

These results suggest that impairments of EF exist even in the earliest stage of the MCI, with a disproportionate decline in the sub-domains of EF.

Keywords: mild cognitive impairment; Alzheimer’s disease; executive function; verbal fluency; psychomotor speed; inhibitory control; mental set-shifting

INTRODUCTION

Executive function (EF) refers to “higher-level” cognitive functions involved in the control and regulation of “lower-level” cognitive processes and goal-directed, future-oriented behaviors.1 EFs include planning, abstract reasoning, processing speed, working memory, cognitive flexibility, set-shifting, inhibitory control, and generative fluency.1 Executive dysfunction is a crucial feature of several neurodegenerative disorders such as fronto-temporal dementia (FTD), Parkinson’s disease (PD), and progressive supranuclear palsy (PSP).2

For many years, Alzheimer’s disease (AD) had been known to have memory dysfunction as an initial and prominent symptom, with the executive function being relatively spared in the early stage of the disease.3 In recent years, however, researchers reported that even mild AD patients exhibit impairments in a variety of EF tests, and over a 2-year period, mild AD with dysexecutive clinical phenotype progresses more rapidly than AD with amnestic phenotype.4 Previous studies have also shown that deficits in EF are common even in amnestic mild cognitive impairment (aMCI).5, 6, 7, 8, 9 A growing body of evidence has shown that aMCI combined other cognitive deficits leads to greater risk for conversion into AD, than in the case of memory dysfunction alone.10 Rozzini et al.11 found that aMCI patients with worsening of EF and functional status but not of memory, were more likely to progress to AD at a 1-year follow up.

Some researchers demonstrated that the Clinical Dementia Rating-Sum of Boxes (CDR-SB) is a more detailed quantitative general index for staging of severity of dementia than the CDR-Global Score (CDR-GS), and is more accurate for tracking changes across time.12, 13 O’Bryant et al.14 suggested that CDR-GS of 0.5 does not represent a homogeneous group, and CDR-SB score of 2.5 may have potential for discriminating between MCI (questionable impairment) and very early AD with CDR-GS of 0.5. Moreover, the Alzheimer’s Disease Neuroimaging Initiative (ADNI Go and ADNI 2) sub-categorized MCI into early MCI (EMCI) and late MCI (LMCI), to predict conversion into AD and to develop intervention strategies for the earliest stages of the disease.15

Although the aforementioned literatures consistently indicate the relationship between executive dysfunction and aMCI as well as AD, there is a lack of research that indicates how early the deficits of EF exist in aMCI. The present study investigated whether executive dysfunctions occur in the earlier stage of aMCI (EMCI), and which sub-domains of EF are disproportionately impaired earlier than others.

METHODS

Participants

Forty-one community-dwelling elders [normal elderly (NE)], without subjective memory complaints, voluntarily participated in the study from July 2015 to September 2015. All were screened based on Christensen’s health screening criteria16 and a total score on the Korean-Mini Mental State Examination (K-MMSE)17 higher than the 16th percentile. The patients with cognitive impairments were selected from the patients who visited the Department of Neurology at Hallym University Sacred Heart Hospital from July 2013 to April 2015. Patients who had a stroke, significant ischemic changes on brain MRI, movement problems, or salient personality changes, were excluded. Eighty-six patients with amnestic multi-domain MCI (aMCI) met Petersen’s criteria for MCI,18 and 41 patients with mild AD, met the clinical criteria for probable AD proposed by the NINCDS-ADRDA.19 All patients underwent brain MRI. Additionally, based on the CDR-SB, 86 aMCI patients with a CDR-GS of 0.5 were classified into EMCI (n=45, CDR-SB: 0.5–2.0) and LMCI (n=41, CDR-SB: 2.5–4.0) subgroups.

Materials and procedure

All participants were administered the Seoul Neuropsychological Screening Battery, 2nd Edition (SNSB-II)20 by trained neuropsychologists, which included measures of attention, language, visuospatial, memory, and frontal/executive functions, as well as the K-MMSE and CDR. We adopted the subtests of frontal/executive function in the SNSB-II for the present study: Go-No go Test, Korean-Color Word Stroop Test (K-CWST), Controlled Oral Word Association Test (COWAT: Semantic and phonemic fluency), Digit Symbol Coding (DSC), and Korean-Trail Making Test-Elderly’s version (K-TMT-E). The score on each test was converted to a standardized z-score, except for the Go-No go test and K-CWST: Word, where raw scores were used.

Statistical analysis

An ANOVA and chi-square test were used to detect group differences for demographic variables such as age, education, and sex. We performed a multivariate analysis of variance (MANOVA) on the z-scores of each test measure. In addition, we did post-hoc analyses with Bonferroni correction for multiple comparisons to analyze group differences. All p-values were two-tailed, and statistical significance was accepted at p<0.05.

RESULTS

Characteristics of demographic variable, K-MMSE and CDR-SB

Demographic variables, K-MMSE score and CDR-SB of the NE, aMCI, and mild AD are presented in Table 1. There were no significant group differences among the NE, aMCI, and mild AD with regards to age, sex, and education. However, significant group differences were observed in the total score of K-MMSE (F(3, 164)=52.73, p<0.001) and CDR-SB (F(2, 124)=54.56, p<0.001). Results of the post-hoc analysis indicated mild AD with the lowest score on the K-MMSE, and the highest score on the CDR-SB. Post-hoc analysis also revealed significant differences between the EMCI and LMCI; the LMCI exhibited poorer performance on the K-MMSE and had a greater score on the CDR-SB than the EMCI, respectively. The NE showed significantly higher score on K-MMSE than the EMCI.


Table 1
Demographic characteristics of the participants, K-MMSE, and CDR-SB
Click for larger image

Profile of executive functions

The EF performances of the four groups included in the study are shown in Table 2. MANOVA revealed a significant difference among groups on EF tests (λ=0.41, F(3, 164)=6.04, p<0.001). Significant group differences were observed in COWAT: Animal (F(3, 164)=18.86, p<0.001), COWAT: Supermarket (F(3, 164)=24.61, p<0.001), COWAT: Phonemics (F(3, 164)=12.00, p<0.001), DSC (F(3, 164)=10.14, p<0.001), Go-No go Test (F(3, 164)=9.78, p<0.001), K-CWST: Color (F(3, 164)=10.69, p<0.001), and K-TMT-E: Part B (F(3, 164)=14.45, p<0.001), but not for K-CWST: Word and K-TMT-E: Part A.


Table 2
Performance on the executive function tests in NE, EMCI, LMCI, and mild AD
Click for larger image

Results of the post-hoc analysis for the COWAT: Animal and Supermarket showed that EMCI was more impaired than the NE, although there were no differences between the EMCI and LMCI. Also, mild AD exhibited worse performance than the EMCI, whereas there were no significant differences between the LMCI and mild AD. With regard to COWAT: Phonemics and DSC, all patient groups revealed significant impairments compared to the NE, but all patient groups were impaired similarly. For the Go-No go Test, K-CWST: Color and K-TMT-E: Part B, there was no difference between the NE and EMCI; however, the LMCI exhibited worse performance than the NE. Although the LMCI revealed no significant difference compare to the EMCI and mild AD, the latter showed poorer performance than the NE and EMCI. There were no significant differences for all groups in the K-CWST: Word and K-TMT-E: Part A.

DISCUSSION

The present study examined whether impairment of EF exists in MCI as well as mild AD, and studied which sub-domains of EF are differentially affected at the earlier stages. The results indicated significant declines of EF in either EMCI or LMCI for 7 out of the 9 measures in 5 EF tests, except in K-CWST: Word and K-TMT-E: Part A.

With regard to the COWAT: Animal and Supermarket, the results indicated that semantic fluency was impaired at the early stage of MCI (EMCI), which gradually worsens up to mild AD. Semantic fluency has been recognized to be dependent not only upon the integrity of semantic memory, but also on executive functioning; semantic fluency is more impaired following focal temporal and frontal lobe damage.21 Previous studies suggest that semantic memory impairment is often present in aMCI as well as in dementia of the Alzheimer’s type. It is said to be associated with injury of the temporal lobe structure.21 In line with the findings of recent literature, the results of the present study indicated that semantic fluency deficits exist even in the earliest stage of the MCI, with progression through AD, suggesting that semantic fluency is a sensitive measure to detect the early stage of aMCI, and could be a good index to monitor the progression to AD.

Results for post-hoc analysis for the COWAT: Phonemics and DSC showed that phonemic fluency and psychomotor speed were impaired at the early stage of aMCI relative to NE, but were maintained at the same level to mild AD, unlike semantic fluency. Phonemic fluency measures the generating of as many words as possible based on orthographic criteria. It requires effortful self-initiated retrieval processing.22 In addition, phonemic fluency imposes greater demands on executive skills, than semantic fluency, and many authors have reported that phonemic fluency is more sensitive to frontal, as opposed to non-frontal, lesions.22 The results of the present study indicated that the effortful self-initiated retrieval processing for words based on lexical representation was already impaired even in the early stage of aMCI. DSC is associated with visuospatial perception, processing speed, sustained attention, visuomotor coordination, and incidental memory. It is especially recognized for use in assessing the psychomotor speed.23 Several authors have emphasized that the marked characteristic of normal aging is the slowing of processing speed,24, 25 which itself is a very sensitive measure of brain abnormality.26 Unlike the DSC, however, we could not find any differences on K-TMT: Part A which is a known measure of processing speed among all groups. This result indicated that DSC is a more sensitive test to detect the impairments of psychomotor speed than TMT: Part A. It also showed that psychomotor slowing was already present at the early stage of aMCI. Recent studies reported that psychomotor slowing is a crucial determinant of performance on verbal fluency tests in normal elderly as well as dementia of the Alzheimer’s type.27 Our results showed the same pattern of decline both in the COWAT: Phonemics and in the DSC, supporting the common role of psychomotor speed for both tests.

With regard to the Go-No go Test, K-CWST: Color naming, and K-TMT-E: Part B, we found that EMCI performed similarly to NE, though inhibitory control and mental set-shifting progressively worsened from MCI (EMCI and LMCI) to mild AD. Go-No go Test and K-CWST (Stroop test) assess the ability to inhibit the automatized or previously learned responses, and select the appropriate responses.5, 6 Some authors have reported that inhibitory control, which is measured by the Hayling and Stroop tests, was the most frequently and severely impaired in aMCI compared to normal elderly controls, relative to other EF tests.5 In contrast, other researchers have shown that tests for inhibition of prepotent responses (Go-No go Test and Stroop tests) failed to uncover significant group differences between normal control and aMCI.6 In our results, we observed that EMCI performed similarly to NE, but LMCI exhibited a poorer performance than NE on the Go-No go Test and K-CWST: Color. K-TMT-E: Part B measures the working memory, divided attention, and processing speed; however, it mainly requires mental set-shifting ability.28 Some authors reported that MCI performed similarly to control group on TMT: Part B,7 whereas other authors found that TMT: Part B was impaired in MCI compared to normal control.6 In the present study, we found that EMCI performed similarly to NE; in contrast, LMCI was more impaired than NE on the K-TMT-E: Part B. Many reasons could explain the inconsistent conclusions of previous studies indicating the use of different tasks, but we believe it is primarily because of different criteria for the recruitment of aMCI patients. In the current study, we subdivided aMCI patients with a CDR-GS of 0.5 into EMCI and LMCI, according to CDR-SB. As a post-hoc analysis, we re-analyzed after merging the two MCI groups (EMCI and LMCI) into one group (aMCI). We found group differences between the aMCI and NE in the Go-No go Test, K-CWST: Color, and K-TMT-E: Part B (Table 3). Since the EMCI, but not LMCI, still maintained the inhibitory control and mental set-shifting abilities, these results supported that subdividing aMCI into EMCI and LMCI based on CDR-SB would help in understanding the spectrum of impairments of EF in the disease, and to identify the progression of dementia.


Table 3
Performance on the executive function tests in NE, aMCI, and mild AD
Click for larger image

To summarize, there were no group differences in simple processing speed among the NE, aMCI, and mild AD. We found that the EMCI performed worse than the NE in verbal fluency and psychomotor speed tests; however, there were no differences between the EMCI and NE in inhibitory control and set-shifting abilities. Also, no differences were observed between the EMCI and LMCI in any of the 9 measures in 5 EF tests; but the LMCI revealed worse performance than the NE in 7 measures. The EMCI exhibited better performance on semantic fluency, Go-No go Test, K-CWST: Color, and K-TMT: Part B than the mild AD; the LMCI did not show any differences with the mild AD on any measures in 5 EF tests.

These results indicated that EF impairments exist even in the earlier stage of the aMCI in several sub-domains, with some sub-domains being similar to NE. This means that the semantic and phonemic fluency and psychomotor speed decline earlier, whereas inhibitory control and mental set-shifting abilities decline later. Functional neuroimaging studies showed that patients with left dorsolateral prefrontal cortex (DLPFC) or inferior frontal gyrus lesions are impaired on verbal fluency,29, 30 whereas psychomotor speed is associated with superior frontal lobe (middle frontal gyrus).26 It has known that anterior cingulate cortex (ACC) and orbitofrontal cortex (OFC) play an important role in Stroop and Go-No go Test performances.31, 32, 33 Set-shifting or cognitive flexibility are also known to be related with increased activation in the DLPFC and medial prefrontal cortex (PFC).34 In addition, some researchers reported that the most substantial age-related decline is the volume of prefrontal grey matter including both DLPFC and OFC areas.35, 36 Several authors, however, found a relative preservation of the OFC and ACC, although they found the strongest volume reduction within the DLPFC regions.35, 37, 38 Taking together these findings from functional and structural neuroimaging with the present study results, we can assume that functions of the PFC which are more related to lateral regions decline at earlier stage of aMCI, whereas the EFs associated with the more orbital or medial part of PFC are impaired at later stage of aMCI.

Our results indicated that executive dysfunction is an important feature of aMCI. Thus, it should be noted that if a clinical setting cannot afford to administer a comprehensive neuropsychological assessment for aMCI, we suggest that at least two kinds of EF tests should be administered for staging aMCI. The results of the present study indicated that the COWAT and DSC are more sensitive for the detection of an early-stage of aMCI, whereas the Go-No go Test, K-CWST: Color, and K-TMT: Part B are useful for the detection of late-stage aMCI.

There are several limitations to the current study. First, this study was retrospective with a relatively small sample size. Second, we could not control the drug effects on each patient group. Third, we did not have biomarker evidences such as hypometabolism, β-amyloid deposition, and cerebrospinal fluid (CSF) proteins which would prove that our aMCI is the prodromal stage of AD, although we excluded patients who had a stroke, significant ischemic changes on brain MRI, movement problems, or salient personality changes. Fourth, all the EF tests included in our study were traditional “paper-and-pencil” tests used in clinical settings. We suggest this study should be replicated using more sensitive experimental tasks that measure the EF in detail. Finally, this study was a cross-sectional study; thus, future research should be conducted as a longitudinal base.

Notes

Conflicts of Interest:The authors have no financial conflicts of interest.

References
1. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006;16:17–42.
2. Miller BL, Cummings JL. In: The Human Frontal Lobes: Functions and Disorders. 2nd. New York: Guilford Press; 2007.
3. Broks P, Lines C, Atchison L, Challenor J, Traub M, Foster C, et al. Neuropsychological investigation of anterior and posterior cortical function in early-stage probable Alzheimer’s disease. Behav Neurol 1996;9:135–148.
4. Dickerson BC, Wolk DA. Alzheimer’s Disease Neuroimaging Initiative. Dysexecutive versus amnesic phenotypes of very mild Alzheimer’s disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry 2011;82:45–51.
5. Johns EK, Phillips NA, Belleville S, Goupil D, Babins L, Kelner N, et al. The profile of executive functioning in amnestic mild cognitive impairment: disproportionate deficits in inhibitory control. J Int Neuropsychol Soc 2012;18:541–555.
6. Zhang Y, Han B, Verhaeghen P, Nilsson LG. Executive functioning in older adults with mild cognitive impairment: MCI has effects on planning, but not on inhibition. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2007;14:557–570.
7. Traykov L, Raoux N, Latour F, Gallo L, Hanon O, Baudic S, et al. Executive functions deficit in mild cognitive impairment. Cogn Behav Neurol 2007;20:219–224.
8. Zheng D, Dong X, Sun H, Xu Y, Ma Y, Wang X. The overall impairment of core executive function components in patients with amnestic mild cognitive impairment: a cross-sectional study. BMC Neurol 2012;12:138.
9. Chen NC, Chang CC, Lin KN, Huang CW, Chang WN, Chang YT, et al. Patterns of executive dysfunction in amnestic mild cognitive impairment. Int Psychogeriatr 2013;25:1181–1189.
10. Summers MJ, Saunders NL. Neuropsychological measures predict decline to Alzheimer’s dementia from mild cognitive impairment. Neuropsychology 2012;26:498–508.
11. Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, et al. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry 2007;22:1217–1222.
12. Lynch CA, Walsh C, Blanco A, Moran M, Coen RF, Walsh JB, et al. The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord 2006;21:40–43.
13. O’Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, et al. Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas Alzheimer’s research consortium study. Arch Neurol 2008;65:1091–1095.
14. O’Bryant SE, Lacritz LH, Hall J, Waring SC, Chan W, Khodr ZG, et al. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer’s coordinating center database. Arch Neurol 2010;67:746–749.
15. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, et al. Clinical core of the Alzheimer’s disease neuroimaging initiative: progress and plans. Alzheimers Dement 2010;6:239–246.
16. Christensen KJ, Multhaup KS, Nordstrom S, Voss K. A cognitive battery for dementia: development and measurement characteristics. J Consult Clin Psychol 1991;3:168–174.
17. Kang YW. A normative study of the Korean-Mini Mental State Examination (K-MMSE) in the elderly. Korean J Psychol Gen 2006;25:1–12.
18. Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med 2011;364:2227–2234.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
20. Kang Y, Jahng SM, Na DL. In: Seoul Neuropsychological Screening Battery, 2nd ed (SNSB-II). Seoul: Human Brain Research & Consulting Co.; 2012.
21. Henry JD, Crawford JR, Phillips LH. Verbal fluency performance in dementia of the Alzheimer’s type: a meta-analysis. Neuropsychologia 2004;42:1212–1222.
22. Henry JD, Crawford JR. A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 2004;18:284–295.
23. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux JM, et al. Cognitive process in preclinical phase of dementia. Brain 1998;121:135–141.
24. Stephens R. Age-related decline in Digit-Symbol performance: eye-movement and video analysis. Arch Clin Neuropsychol 2006;21:101–107.
25. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996;103:403–428.
26. Turken A, Whitfield-Gabrieli S, Bammer R, Baldo JV, Dronkers NF, Gabrieli JD. Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage 2008;42:1032–1044.
27. Rodríguez-Aranda C, Waterloo K, Sparr S, Sundet K. Age-related psychomotor slowing as an important component of verbal fluency: evidence from healthy individuals and Alzheimer’s patients. J Neurol 2006;253:1414–1427.
28. Muir RT, Lam B, Honjo K, Harry RD, McNeely AA, Gao FQ, et al. Trail Making Test elucidates neural substrates of specific poststroke executive dysfunctions. Stroke 2015;46:2755–2761.
29. Paulesu E, Goldacre B, Scifo P, Cappa SF, Gilardi MC, Castiglioni I, et al. Functional heterogeneity of left inferior frontal cortex as revealed by fMRI. Neuroreport 1997;8:2011–2017.
30. Phelps EA, Hyder F, Blamire AM, Shulman RG. FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 1997;8:561–565.
31. Botvinick MM, Cohen JD, Carter CS. Conflict monitoring and anterior cingulate cortex: an update. Trends Cogn Sci 2004;8:539–546.
32. Menon V, Adleman NE, White CD, Glover GH, Reiss AL. Error-related brain activation during a Go/NoGo response inhibition task. Hum Brain Mapp 2001;12:131–143.
33. Rolls ET, Hornak J, Wade D, McGrath J. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. J Neurol Neurosurg Psychiatry 1994;57:1518–1524.
34. Zakzanis KK, Mraz R, Graham SJ. An fMRI study of the Trail Making Test. Neuropsychologia 2005;43:1878–1886.
35. Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex 1997;7:268–282.
36. Tisserand DJ, Pruessner JC, Sanz Arigita EJ, van Boxtel MP, Evans AC, Jolles J, et al. Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. Neuroimage 2002;17:657–669.
37. Salat DH, Kaye JA, Janowsky JS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol 2001;58:1403–1408.
38. Tisserand DJ, van Boxtel M, Gronenschild E, Jolles J. Age-related volume reductions of prefrontal regions in healthy individuals are differential. Brain Cogn 2001;47:182–185.